Predicted dolutegravir resistance in people living with HIV in South Africa during 2020-35: a modelling study.

Saved in:
Bibliographic Details
Title: Predicted dolutegravir resistance in people living with HIV in South Africa during 2020-35: a modelling study.
Authors: Loosli T; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Han N; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Hauser A; Department of Epidemiology and Health Systems, Unisanté, Center for Primary Care and Public Health and University of Lausanne, Lausanne, Switzerland., Josi J; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Ingle SM; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., van Sighem A; Stichting HIV Monitoring, Amsterdam, Netherlands., Wittkop L; Bordeaux Population Health U1219, Université de Bordeaux, Institut National de la Santé et de la Recherche Médicale, Bordeaux, France; Statistics in System Biology and Translational Medicine, National Institute for Research in Digital Science and Technology, Bordeaux, France; Service d'information Médicale, Centre d'Investigation Clinique-Epidémiologie Clinique 1401, Centre Hospitalier Universitaire de Bordeaux, Institut National de la Santé et de la Recherche Médicale, Bordeaux, France., Vehreschild J; Institute for Digital Medicine and Clinical Data Sciences, Goethe University, Frankfurt, Germany; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; German Centre for Infection Research, Cologne, Germany., Ceccherini-Silberstein F; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy., Maartens G; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Gill MJ; Southern Alberta Clinic, Calgary, AB, Canada; Department of Medicine, University of Calgary, Calgary, AB, Canada., Sabin CA; Institute for Global Health, University College London, London, UK., Johnson LF; Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa., Lessells R; KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa., Günthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Egger M; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Kouyos RD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland. Electronic address: roger.kouyos@uzh.ch.
Source: The Lancet. Global health [Lancet Glob Health] 2025 Apr; Vol. 13 (4), pp. e698-e706.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101613665 Publication Model: Print Cited Medium: Internet ISSN: 2214-109X (Electronic) Linking ISSN: 2214109X NLM ISO Abbreviation: Lancet Glob Health Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40155107
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Predicted dolutegravir resistance in people living with HIV in South Africa during 2020-35: a modelling study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Loosli+T%22">Loosli T</searchLink>; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Han+N%22">Han N</searchLink>; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hauser+A%22">Hauser A</searchLink>; Department of Epidemiology and Health Systems, Unisanté, Center for Primary Care and Public Health and University of Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Josi+J%22">Josi J</searchLink>; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ingle+SM%22">Ingle SM</searchLink>; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22van+Sighem+A%22">van Sighem A</searchLink>; Stichting HIV Monitoring, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Wittkop+L%22">Wittkop L</searchLink>; Bordeaux Population Health U1219, Université de Bordeaux, Institut National de la Santé et de la Recherche Médicale, Bordeaux, France; Statistics in System Biology and Translational Medicine, National Institute for Research in Digital Science and Technology, Bordeaux, France; Service d'information Médicale, Centre d'Investigation Clinique-Epidémiologie Clinique 1401, Centre Hospitalier Universitaire de Bordeaux, Institut National de la Santé et de la Recherche Médicale, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Vehreschild+J%22">Vehreschild J</searchLink>; Institute for Digital Medicine and Clinical Data Sciences, Goethe University, Frankfurt, Germany; Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; German Centre for Infection Research, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Ceccherini-Silberstein+F%22">Ceccherini-Silberstein F</searchLink>; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Maartens+G%22">Maartens G</searchLink>; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Gill+MJ%22">Gill MJ</searchLink>; Southern Alberta Clinic, Calgary, AB, Canada; Department of Medicine, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Sabin+CA%22">Sabin CA</searchLink>; Institute for Global Health, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Johnson+LF%22">Johnson LF</searchLink>; Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Lessells+R%22">Lessells R</searchLink>; KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.<br /><searchLink fieldCode="AU" term="%22Günthard+HF%22">Günthard HF</searchLink>; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Egger+M%22">Egger M</searchLink>; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kouyos+RD%22">Kouyos RD</searchLink>; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland; Institute of Medical Virology, University of Zurich, Zurich, Switzerland. Electronic address: roger.kouyos@uzh.ch.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101613665%22">The Lancet. Global health</searchLink> [Lancet Glob Health] 2025 Apr; Vol. 13 (4), pp. e698-e706.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101613665 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2214-109X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222214109X%22">2214109X </searchLink><i>NLM ISO Abbreviation: </i>Lancet Glob Health <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40155107
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2214-109X(24)00553-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e698
    Titles:
      – TitleFull: Predicted dolutegravir resistance in people living with HIV in South Africa during 2020-35: a modelling study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Loosli T
      – PersonEntity:
          Name:
            NameFull: Han N
      – PersonEntity:
          Name:
            NameFull: Hauser A
      – PersonEntity:
          Name:
            NameFull: Josi J
      – PersonEntity:
          Name:
            NameFull: Ingle SM
      – PersonEntity:
          Name:
            NameFull: van Sighem A
      – PersonEntity:
          Name:
            NameFull: Wittkop L
      – PersonEntity:
          Name:
            NameFull: Vehreschild J
      – PersonEntity:
          Name:
            NameFull: Ceccherini-Silberstein F
      – PersonEntity:
          Name:
            NameFull: Maartens G
      – PersonEntity:
          Name:
            NameFull: Gill MJ
      – PersonEntity:
          Name:
            NameFull: Sabin CA
      – PersonEntity:
          Name:
            NameFull: Johnson LF
      – PersonEntity:
          Name:
            NameFull: Lessells R
      – PersonEntity:
          Name:
            NameFull: Günthard HF
      – PersonEntity:
          Name:
            NameFull: Egger M
      – PersonEntity:
          Name:
            NameFull: Kouyos RD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2025 Apr
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2214-109X
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: The Lancet. Global health
              Type: main
ResultId 1